It’s all about the money.
Should that surprise us?
“For the love of money is the root of all evil: which while some coveted after, they have erred from the faith, and pierced themselves through with many sorrows” (1 Timothy 6:10).
The Bible does not say that “money” is the root of all evil; it says that the root of all evil is the love of money. Money, in and of itself, can be used for good and noble causes, but for many people, money has become their god.
Obama, Congress and FDA
While much of America was busy rejoicing over the election of Donald Trump, Congress quietly pushed through legislation which was great for Big Pharma, but for the unsuspecting America people – not so much. This legislation, which was passed by both sides of the political isle, is called “21st Century Cures.” As usual, the bill has hundreds of pages. This is a tactic used by the left to push through legislation quickly. They know that no one is going to sit and read this drivel – easier to just pass it.
What you need to know about 21st Century Cures Act:
From naturalsociety.c0m (Article written right before Act was approved in Dec 2016)
Congress Prepares To Vote On Bill That Would Speed Up Drug Approval
Sometimes rushing the process costs people their lives
Congress will vote today on a nearly 1,000-page bill that holds drastic changes for the U.S. Food and Drug Administration (FDA). If the bill is approved, it would speed up the approval of new drugs and medical devices. The House has been heavily criticized for allegedly rushing piece of legislation through without sufficient scrutiny.
The legislation, dubbed the 21st Century Cures Act, sets aside $6.3 billion for biomedical research, opioid abuse prevention, and support for the FDA, which oversees the safety of drugs. Multiple provisions are contained in the bill that are designed to loosen the requirements for drugmakers seeking approval from the agency to market their products.
Lawmakers on both sides of the aisle largely support the bill, but consumer advocates say major trade-offs in the legislation could actually strip the FDA of some of its regulatory power. Sen. Elizabeth Warren (D-Mass.) and other lawmakers argue the bill contains giveaways for the pharmaceutical industry.
In a tweet dated November 28, Sen. Warren said:
“Congress has been working on medical innovation legislation for yrs. But in the final days of 2016, Big Pharma hijacked 21st Century Cures.”
Drug and medical device companies are thrilled with the legislation, which lobbyists have been working overtime to try and get passed. According to the Center for Responsive Politics, more than 1,400 lobbyists have pushed for the bill’s passage, including drug companies and universities, which would all benefit from an increase in biomedical research funding.
A version of the bill that passed easily in Congress ended up dying in the Senate. The updated version, unveiled by House and Senate leaders over Thanksgiving weekend, has been altered to speed its passage through both houses.
Are Drugs Being Approved Fast Enough Now?
Dr. Michael Carome, director of Public Citizen Health Research Group, is concerned that, under the bill, drugs would be approved by the FDA even faster than they are today. And make no mistake about it, the agency already rushes medications to the market.
There are 4 possible channels for the FDA to expedite approval for promising new drugs for the treatment of serious or life-threatening medical conditions. These programs were intended to be an exception to the rule; however, a 2015 study in the BMJ showed that the programs have become the rule themselves, with a statistically significant increase of 2.6% per year over the last 20 years in the number of drugs qualifying for the FDA’s expedited drug development and approval programs.
Read: 4 Crucial Ways the FDA has Failed us
The FDA can approve drugs based on the presumption that they work, but without proof of a long-term benefit. Researchers use a “surrogate endpoint,” such as a tumor’s response to a drug, even though that response might not translate into a longer or healthier life.
Most of these early approvals and developments rely on information gathered from early-stage trials that are generally small in size. The authors of the report wrote that “this trend is being driven by drugs that are not first in class and thus potentially less innovative.” In fact, according to Diana Zuckerman, head of the National Center for Health Research, 1 study revealed that 18 of the 36 the cancer drugs recently approved on the basis of surrogate endpoints failed to help people live longer. She says:
“What’s happening is we are flooding the market with medical products that don’t work very well, or we don’t know whether they work.”
Fast-Tracking Can Be A Problem
But fast-tracking drugs has cost people their lives in the past. The best example of this is Vioxx, a non-steroidal anti-inflammatory drug (NSAID). During the review process for the pain reliever, an FDA medical officer looking at clinical trials noted a threefold increase in cardiovascular problems by people taking it, but could not definitively say Vioxx was the cause.
At the time, Celebrex, a similar drug, was already on the market. Yet, the FDA fast-tracked Vioxx with the goal of making a decision within 6 months.
Within 6 months, another Vioxx clinical trial showed that people taking the drug had double the number of heart attacks and strokes. Merck, the maker of Vioxx, took the medication off the market. A standard review of Vioxx – and the FDA’s insistence on better studies, earlier in the process – could have led the agency to restrict who used the drug or delay its arrival on the market. (emphasis added)
By the time Merck pulled Vioxx in 2004, more than 38,000 deaths related to its use had been reported, and as many as 25 million Americans had taken the drug. –source
21st Century Cures or Corruption?
The only beneficiaries of the 21st Century Cures Act introduced in Congress last year are the drug, vaccine and medical device manufacturers, as this proposed legislation was designed to speed up experimental drug and vaccine approvals, cut corners on pre-licensure testing and narrow or eliminate informed consent protections in scientific research on humans.
The bill, which easily passed the House of Representatives last summer but got stalled in the Senate, earmarked more than $8 billion to NIH for new drug research while relaxing FDA safety oversight.
This year, Senators supporting passage of the Act cut it up into separate smaller bills to achieve their goal of fast tracking new products to market by avoiding drug, vaccine and medical device safety mechanisms. – source
** Note: This legislation was passed in Dec of 2016.
I want to offer some other credible websites for the readers to be able to access for more information:
Brethren, if you watch any amount of TV each day, certainly you have been bombarded with commercials about pharmaceutical drugs for every illness known to man. Have you listened as they reveal the possible side effects of these drugs? Have you noticed that the person who rattles off the possible side effects is hard to understand because of the speeding up of their voice? That is no accident. By law, they must tell the public what possible side effects may be associated with the drug.
Here are some of the “oh, by the way” side effects:
Immune system shutdowns
And now they want to SPEED UP the process of approval of these lethal drugs?
Do your own research. If your doctor is pushing this medicine or that medicine on you – first of all, look the medicine up. Secondly, research a natural way to treat your condition. There are some drugs which are absolutely critical for survival i.e. Insulin.
It’s up to you.
You can fully trust your doctor, or you can be your own advocate and research for yourself!
If you would like to bless us with a gift, please send to:
P.O. Box 1031
Savage, MD 20763
Your generosity is most appreciated!
Please remember that “gifts” are not tax deductible.